Table 2 Heart failure drug treatment on admission for patients with previous heart failure, with analysis of age and gender effects

Drug	Women No (%)	Men No (%)	OR (95% CI) for men	p Value	OR (95% CI) for age*	p Value
No HF drug	38 (1.8)	38 (1.5)	0.77 (0.48 to 1.22)	0.261	0.99 (0.97 to 1.01)	0.174
Diuretic alone	391 (18.5)	352 (13.6)	0.81 (0.69 to 0.96)	0.013	1.04 (1.03 to 1.05)	<0.001
Diuretic	1761 (83.3)	2154 (83.1)	1.03 (0.88 to 1.20)	0.734	1.01 (1.00 to 1.02)	0.013
ACE/AIIRA	1233 (58.3)	1731 (66.8)	1.29 (1.14 to 1.45)	<0.001	0.97 (0.97 to 0.98)	<0.001
β-Blocker	655 (30.1)	920 (35.5)	1.15 (1.01 to 1.29)	0.033	0.98 (0.97 to 0.99)	<0.001
Aldosterone antagonist	400 (18.9)	582 (22.5)	1.14 (0.98 to 1.31)	0.087	0.98 (0.97 to 0.99)	<0.001
Diuretic and ACE/AIIRA	1064 (50.3)	1528 (58.9)	1.31 (1.16 to 1.48)	<0.001	0.98 (0.97 to 0.98)	<0.001
All four drugs	80 (3.8)	190 (7.3)	1.74 (1.33 to 2.29)	<0.001	0.97 (0.96 to 0.98)	<0.001

AIIRA, angiotensin II receptor antagonist; HF, heart failure.
*OR per year of increasing age.